Published in Neurology on September 13, 2005
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90
Frontotemporal dementia: clinicopathological correlations. Ann Neurol (2006) 5.14
Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family. J Neurol Neurosurg Psychiatry (2010) 3.66
Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch Neurol (2008) 3.03
Rapidly progressive dementia. Ann Neurol (2008) 3.00
Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease. J Neurosci (2011) 2.96
Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. Neurology (2011) 2.61
Primary progressive aphasia: clinicopathological correlations. Nat Rev Neurol (2010) 2.19
Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs (2010) 1.72
Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol (2013) 1.68
Rapidly progressive dementia. Neurol Clin (2007) 1.58
A tensor based morphometry study of longitudinal gray matter contraction in FTD. Neuroimage (2007) 1.45
Comparison of cerebrospinal fluid levels of tau and Aβ 1-42 in Alzheimer disease and frontotemporal degeneration using 2 analytical platforms. Arch Neurol (2012) 1.42
The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathol (2012) 1.42
The non-fluent/agrammatic variant of primary progressive aphasia. Lancet Neurol (2012) 1.33
Estimating the number of persons with frontotemporal lobar degeneration in the US population. J Mol Neurosci (2011) 1.25
Selective frontoinsular von Economo neuron and fork cell loss in early behavioral variant frontotemporal dementia. Cereb Cortex (2011) 1.24
Anterior insula degeneration in frontotemporal dementia. Brain Struct Funct (2010) 1.24
Determinants of survival in behavioral variant frontotemporal dementia. Neurology (2009) 1.20
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier). Alzheimers Dement (2012) 1.14
Frontotemporal dementias: a review. Ann Gen Psychiatry (2007) 1.11
The epidemiology of frontotemporal dementia. Int Rev Psychiatry (2013) 1.09
Mouse models of frontotemporal dementia. Ann Neurol (2012) 1.01
Frontotemporal dementia: a bridge between dementia and neuromuscular disease. Ann N Y Acad Sci (2014) 0.93
Advanced practice nursing: meeting the caregiving challenges for families of persons with frontotemporal dementia. Clin Nurse Spec (2010) 0.90
Verbal fluency predicts mortality in Alzheimer disease. Cogn Behav Neurol (2006) 0.89
Diagnosis and management of behavioral variant frontotemporal dementia. Biol Psychiatry (2013) 0.88
Factors affecting survival of patients with neurodegenerative disease. Neuroepidemiology (2010) 0.87
History, present, and progress of frontotemporal dementia in china: a systematic review. Int J Alzheimers Dis (2012) 0.87
What is the life expectancy in frontotemporal lobar degeneration? Neuroepidemiology (2011) 0.85
Three-Class Differential Diagnosis among Alzheimer Disease, Frontotemporal Dementia, and Controls. Front Neurol (2014) 0.84
Behavioral variant frontotemporal dementia with corticobasal degeneration pathology: phenotypic comparison to bvFTD with Pick's disease. J Mol Neurosci (2011) 0.83
Predictors of mortality in nursing home residents with advanced dementia. Am J Alzheimers Dis Other Demen (2010) 0.83
Primary progressive aphasias and their contribution to the contemporary knowledge about the brain-language relationship. Neuropsychol Rev (2011) 0.81
Frontotemporal dementia: diagnosis, deficits and management. Neurodegener Dis Manag (2014) 0.79
Using the revised diagnostic criteria for frontotemporal dementia in India: evidence of an advanced and florid disease. PLoS One (2013) 0.79
Primary progressive aphasia: relationship between gender and severity of language impairment. Cogn Behav Neurol (2007) 0.79
Alzheimer's disease neuropathologic changes in semantic dementia. Neurocase (2009) 0.79
Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes. Alzheimers Dement (Amst) (2015) 0.78
Social cognition in Alzheimer's disease: a separate construct contributing to dependence. Alzheimers Dement (2014) 0.77
Data-driven regions of interest for longitudinal change in frontotemporal lobar degeneration. Neuroimage Clin (2015) 0.77
Data-driven regions of interest for longitudinal change in three variants of frontotemporal lobar degeneration. Brain Behav (2017) 0.75
Frontotemporal dementia complicated by comorbid borderline personality disorder: a case report. Psychiatry (Edgmont) (2009) 0.75
Biomarkers in the primary progressive aphasias. Aphasiology (2014) 0.75
Extending the administration time of the letter fluency test increases sensitivity to cognitive status in aging. Exp Aging Res (2009) 0.75
Progress in the last decade in our understanding of primary progressive aphasia. Ann Indian Acad Neurol (2010) 0.75
Unusually long duration and delayed penetrance in a family with FTD and mutation in MAPT (V337M). Am J Med Genet B Neuropsychiatr Genet (2016) 0.75
Relative Incidence of Seizures and Myoclonus in Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Dementia. J Alzheimers Dis (2017) 0.75
Syndromes of Rapidly Progressive Cognitive Decline-Our Experience. J Neurosci Rural Pract (2017) 0.75
Measuring disease progression in corticobasal syndrome. J Neurol (2014) 0.75
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology (1998) 26.77
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Alpha-synuclein in Lewy bodies. Nature (1997) 20.83
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
Non-chromosomal antibiotic resistance in bacteria. II. Molecular nature of R-factors isolated from Proteus mirabilis and Escherichia coli. J Mol Biol (1970) 11.86
Classification of primary progressive aphasia and its variants. Neurology (2011) 11.82
Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol (2001) 9.96
Neurodegenerative tauopathies. Annu Rev Neurosci (2001) 9.53
Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med (2001) 9.51
Multiple molecular species of circular R-factor DNA isolated from Escherichia coli. Nature (1969) 9.02
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology (2009) 7.04
Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain (2008) 6.29
Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol (1997) 6.12
Central obesity and increased risk of dementia more than three decades later. Neurology (2008) 6.03
Comparing predictors of conversion and decline in mild cognitive impairment. Neurology (2010) 5.69
Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science (2000) 5.62
A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science (1991) 5.60
Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol (1998) 5.47
Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2001) 5.12
Midlife cardiovascular risk factors and risk of dementia in late life. Neurology (2005) 5.12
Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest (2000) 5.07
Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology (2002) 5.03
MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. Brain (2009) 4.51
Longitudinal observations on a selected group of local health departments: a preliminary report. J Public Health Policy (1993) 4.50
Relationships between biomarkers in aging and dementia. Neurology (2009) 4.16
In vivo nitrate reduction in relation to nitrate uptake, nitrate content, and in vitro nitrate reductase activity in intact barley seedlings. Plant Physiol (1976) 4.16
Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol (1996) 4.10
Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science (1998) 4.07
A survey of local public health departments and their directors. Am J Public Health (1977) 4.03
A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J Biol Chem (2000) 3.97
The logopenic/phonological variant of primary progressive aphasia. Neurology (2008) 3.95
Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci (2000) 3.90
Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron (1997) 3.73
MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology (2009) 3.72
Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology (2007) 3.71
Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron (1999) 3.49
Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron (1993) 3.45
Epitopes that span the tau molecule are shared with paired helical filaments. Neuron (1988) 3.28
Are amyotrophic lateral sclerosis patients cognitively normal? Neurology (2003) 3.21
Physicians who kill themselves. Arch Gen Psychiatry (1973) 3.20
Race/ethnic differences in AD survival in US Alzheimer's Disease Centers. Neurology (2007) 3.18
Predicting risk of dementia in older adults: The late-life dementia risk index. Neurology (2009) 2.92
Longitudinal volumetric MRI change and rate of cognitive decline. Neurology (2005) 2.90
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes. Leukemia (2013) 2.85
Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proc Natl Acad Sci U S A (1999) 2.85
MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations. Neurology (2009) 2.83
Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med (2000) 2.81
Validity of sexual histories in a prospective study of male sexual contacts of men with AIDS or an AIDS-related condition. Am J Epidemiol (1988) 2.81
Non-chromosomal antibiotic resistance in bacteria. 3. Isolation of the discrete transfer unit of the R-factor R1. Proc Natl Acad Sci U S A (1970) 2.76
The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging. Exp Neurol (1999) 2.73
CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease. Neurology (2010) 2.67
11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology (2007) 2.65
Glucocerebrosidase mutations are an important risk factor for Lewy body disorders. Neurology (2006) 2.65
Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. Neurology (2011) 2.61
Direct and indirect gene replacements in Aspergillus nidulans. Mol Cell Biol (1985) 2.61
Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol (1997) 2.60
Home delivery and neonatal mortality in North Carolina. JAMA (1980) 2.49
Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann Neurol (1998) 2.47
Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum. Neurology (2009) 2.46
Alzheimer disease and frontotemporal dementias. Behavioral distinctions. Arch Neurol (1996) 2.45
Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia. Neurology (2007) 2.43
Recent changes in selected local health departments: implications for their capacity to guarantee basic medical services. Am J Prev Med (1988) 2.43
Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology (2011) 2.42
Predictors of brain morphology for the men of the NHLBI twin study. Stroke (1999) 2.41
Behavioral disorders in the frontal and temporal variants of frontotemporal dementia. Neurology (2004) 2.37
Synucleinopathies: clinical and pathological implications. Arch Neurol (2001) 2.36
Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology (2002) 2.35
Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells. Lab Invest (1992) 2.30
Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc Natl Acad Sci U S A (1999) 2.30
Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology (2000) 2.27
Apathy is not depression. J Neuropsychiatry Clin Neurosci (1998) 2.24
Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology (2004) 2.23
Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol (2001) 2.22
The natural history of temporal variant frontotemporal dementia. Neurology (2005) 2.22
Optic-nerve degeneration in Alzheimer's disease. N Engl J Med (1986) 2.20
Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology (2010) 2.20
Induction of alpha-synuclein aggregation by intracellular nitrative insult. J Neurosci (2001) 2.16
Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J Clin Microbiol (2006) 2.15
Alzheimer's A beta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat Med (1997) 2.15
Two-stage expression of neurofilament polypeptides during rat neurogenesis with early establishment of adult phosphorylation patterns. J Neurosci (1987) 2.15
StuA is required for cell pattern formation in Aspergillus. Genes Dev (1992) 2.14
DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study. Neurology (2003) 2.14
Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro. J Biol Chem (1999) 2.13
Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci U S A (1998) 2.13
Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron (1994) 2.13
Communication and decision-making in seriously ill patients: findings of the SUPPORT project. The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc (2000) 2.12
MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology (2001) 2.11
Genital herpetic infection. Association with cervical dysplasia and carcinoma. Cancer (1969) 2.10